Skip to content

Clinical trials

Coronary Disease trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Country / region: Czechia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20063
20084
20093
20111
20122
20141
20192
20201
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
GlaxoSmithKline2
OrbusNeich2
Sanofi2
Abbott Medical Devices1
Amgen1
AstraZeneca1
Boehringer Ingelheim1
Fibrex Medical Research & Development GmbH1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease21
Cardiovascular Diseases5
Coronary Artery Disease4
Heart Diseases4
Myocardial Ischemia4
Atherosclerosis3
Coronary Stenosis2
Dyslipidemias2
Myocardial Infarction2
Acute Coronary Syndrome1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.